Engineered pluripotent stem cell-derived cardiomyocytes prevent serious engraftment-related arrhythmia in nonhuman primates

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Associate Professor Kenta Nakamura

University of Washington, Seattle (United States of America)

4 More presentations in this session

Presentation thumbnail

Investigation of a novel SLC4A3 variant causing short QT Syndrome: functional and pharmacological evaluation in a knock-in zebrafish model

Ms M. Zhu (Suita, JP)

Abstract Slides Video

Presentation thumbnail

SGK1 inhibition shortens action potential duration and exerts anti-arrhythmic effects in LQT3 mice and LQT2 rabbits by reducing enhanced late sodium current

Doctor S. Casini (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

DECA11 selectively increases human INa and IK1 and is antiarrhythmic in a mouse model of heart failure

Professor R. Caballero (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

Atrial electrophysiological disturbances caused by disruption of the RBM20 splicing factor

Mr L. Weirauch (Heidelberg, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Molecular and cellular drivers of arrhythmia

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Cardiac organoids as regenerative therapy in a preclinical model of acute myocardial infarction-Corrected version

Congress Presentation

Genetic approaches to restore cardiac conduction and prevent ventricular arrhythmias

Congress Presentation

Upregulation of the sodium potassium pump current supresses ectopic activity after stem cell delivery in the human-based heart after myocardial infarction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources